Overview
Benoit Schreck practices in Nantes, France. Mr. Schreck is rated as an Advanced expert by MediFind in the treatment of Cannabinoid Hyperemesis Syndrome (CHS). His top areas of expertise are Cannabinoid Hyperemesis Syndrome (CHS), Opioid Use Disorder, Attention Deficit Hyperactivity Disorder (ADHD), and Hyperemesis Gravidarum.
His clinical research consists of co-authoring 20 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Cannabinoid Hyperemesis Syndrome (CHS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cannabinoid Hyperemesis Syndrome (CHS)
- Experienced
- Attention Deficit Hyperactivity Disorder (ADHD)
- Hyperemesis GravidarumMr. Schreck isExperienced. Learn about Hyperemesis Gravidarum.
- Morning SicknessMr. Schreck isExperienced. Learn about Morning Sickness.
- Opioid Use DisorderMr. Schreck isExperienced. Learn about Opioid Use Disorder.